Skip to main content
Premium Trial:

Request an Annual Quote

Mary Lopez

Mary Lopez has joined Nuclea Biotechnologies as chief operating officer. Her main responsibility will be commercializing the company's US Food and Drug Administration-approved and CLIA-based tests. Lopez was most recently the director of Thermo Fisher Scientific's Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center. Prior to joining Thermo Fisher, she was strategic collaborations leader and analytical proteomics business leader at PerkinElmer Life and Analytical Sciences, and executive vice president of proteomics research and development at Proteome Systems.